Skip to content

Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus.

Juan Pablo Yasmo Perez, Carolina Chegwin Angarita, Omar David Saldarriaga Ochoa, Sergio Andrés Urrego Restrepo

Talanta February 21, 2025 DOI: 10.1016/j.talanta.2025.127777 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Analytical method development and validation study Peer reviewed
Sample size 19
Population Dried fruiting bodies of mushrooms marketed as Psilocybe species, from the Antioquia region near Medellín, Colombia
Keywords Agaricales Fruiting bodies, fungal Methanol Tryptamines Psilocybe Limit of detection
Key points The validated HPLC-DAD method was judged suitable for analyzing tryptamines in mushrooms. Across 19 fungal samples from Antioquia, total tryptamine content ranged from 0.01% to 0.73% expressed in psilocin equivalents per fungal biomass.

Abstract

This study presents the development and validation of a high-performance liquid chromatography method with diode array detection (HPLC-DAD) for determining the content of tryptamines in methanolic extracts of dried fruiting bodies of mushrooms belonging to species of the Psilocybe genus. The objective is to initiate the assessment of tryptamine content in fungi marketed as Psilocybes in Colombia, using a standard chromatographic method that can be replicated. The separation was conducted in reverse phase using a Synergi 4 μm Hydro-RP C18 column (150 × 4.6 mm), eluted in a gradient mode with water-trifluoroacetic acid (100:0.1 v/v) and acetonitrile-trifluoroacetic acid (100:0.1 v/v) as the mobile phase. The gradient started at 5 % B at 0 min, reaching 30 % B at 15 min, with a flow rate of 0.20-0.22 mL/min, a column temperature of 35 ± 2 °C, and an injection volume of 10 μL. After establishing chromatographic conditions, the method was validated in terms of selectivity, linearity, system suitability, precision, robustness, and limits of detection and quantification, following the guidelines recommended by the International Conference on Harmonization (ICH) and the U.S. Food and Drug Administration (FDA). Once the mentioned parameters were evaluated, it was concluded that the method is suitable for the analysis of tryptamines in mushrooms. These conditions enabled the comparison of tryptamine content in 19 fungal samples from the Antioquia region (near Medellín city, Colombia), revealing a total content ranging from 0.01 % to 0.73 % of tryptamines in psilocin equivalents per fungal biomass.